Stately Bio, a biotechnology startup founded by Frank Li, who previously led the machine-learning group at Calico, has officially launched after three years in stealth mode. The company has raised $12 million in seed funding to develop a new approach to studying cells using artificial intelligence and machine learning-powered imaging. This launch comes amid growing interest and investment in the longevity industry, which aims to extend healthy human lifespan and potentially reverse aging processes. Researchers and investors, particularly in the United States, are channeling billions into biotech startups focused on longevity, including targeting senescent cells to improve health outcomes. Industry experts view longevity as a transformative lens for reshaping healthcare and accelerating advancements in the longevity economy.